Perspective Therapeutics, Inc. (CATX) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-03-04

Perspective Therapeutics, Inc. (CATX) — no SEC Form 4 insider filings recorded in the last 90 days. 7 Form 8-K material event filings were reported by CATX in the last 90 days. InsiderAlpha tracks every CATX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Perspective Therapeutics, Inc. (CATX)

SEC CIK	0000728387

90-Day SEC Filing Activity

Form 8-K filings (90d)	7
Latest Form 4 filing	2026-03-04

Recent CATX Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2025-11-13	Hunt Jonathan Robert	Chief Accounting Officer	P — Open-market purchase	11.0K	$2.03	$22K	SEC
2025-11-12	Williamson Robert F III	Insider	P — Open-market purchase	9.5K	$2.10	$20K	SEC
2024-12-04	Spoor Johan M.	CEO	P — Open-market purchase	8.0K	$3.77	$30K	SEC
2024-12-04	HENSON HEIDI	Insider	P — Open-market purchase	26.0K	$3.85	$100K	SEC
2024-11-25	Hunt Jonathan Robert	Chief Financial Officer	P — Open-market purchase	10.0K	$3.88	$39K	SEC
2024-11-25	Williamson Robert F III	Insider	P — Open-market purchase	3.6K	$3.62	$13K	SEC
2024-11-25	Williamson Robert F III	Insider	P — Open-market purchase	2.6K	$3.67	$10K	SEC
2024-11-25	Spoor Johan M.	CEO	P — Open-market purchase	14.5K	$3.78	$55K	SEC
2024-11-25	Spoor Johan M.	CEO	P — Open-market purchase	5.4K	$3.80	$21K	SEC
2024-11-25	Spoor Johan M.	CEO	P — Open-market purchase	6.6K	$3.80	$25K	SEC
2024-11-25	Hunt Jonathan Robert	Chief Financial Officer	P — Open-market purchase	400	$3.55	$1K	SEC
2024-11-25	Hunt Jonathan Robert	Chief Financial Officer	P — Open-market purchase	29	$3.94	$114	SEC
2024-11-25	Hunt Jonathan Robert	Chief Financial Officer	P — Open-market purchase	2.4K	$3.60	$9K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Perspective Therapeutics, Inc. (CATX). Updated in real time as new filings are submitted to the SEC.

Recent CATX Form 8-K Material Events

2026-07-01 — Item 8.01, 9.01 [SEC]
2026-06-01 — Item 8.01, 9.01 [SEC]
2026-05-27 — Item 5.07 [SEC]
2026-05-21 — Item 8.01, 9.01 [SEC]
2026-05-11 — Item 2.02, 8.01, 9.01 [SEC]

Recent Insider Filings

2026-03-04 — Martinez Maria E (Insider)
2026-03-04 — Morich Frank (Insider)
2026-03-04 — Williamson Robert F III (Insider)
2026-03-04 — HENSON HEIDI (Insider)
2026-03-04 — Woods Lori A (Insider)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CATX insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

CATX Insider Trading — FAQ

What is the latest insider trade for CATX?: Perspective Therapeutics, Inc. (CATX) had 0 insider filings in the last 90 days, with the most recent on 2026-03-04. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying CATX stock?: 0 insider purchases of CATX were filed in the last 90 days.
How many insiders are selling CATX stock?: 0 insider sales of CATX were filed in the last 90 days.
Where can I see CATX SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every CATX SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live CATX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.